The Friday Breeze
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
Happy Friday! I come bearing a medical ethical quandary for you to mull as you head into your weekend. Stumped mid-surgery, a renowned doctor turned to old anatomical drawings that had been created by Nazis (and are, to this day, considered unsurpassed in comprehensiveness and precision). She was left with the question: Were they OK to use?
Now on to what you may have missed this week.
If you thought the topic of abortion was going anywhere anytime soon, you’d be very wrong! (Although, let’s be honest, were any of us expecting an end to the debate?) In terms of health care, it dominated this week’s news cycle.
Let’s start with 2020 hopeful Sen. Kamala Harris’ plan to protect abortion rights. Borrowing logic from the Voting Rights Act, the plan from Harris (D-Calif.) would require states with a history of unconstitutionally restricting abortion rights to obtain federal approval from the Department of Justice before such laws could take effect. Where it gets tricky is determining which states would fall under the requirements: the formula used in the VRA was ruled unconstitutional by the Supreme Court in 2013.
The New York Times: Kamala Harris Wants to Require States to Clear Abortion Laws With Justice Dept.
Meanwhile, the Supreme Court performed a delicate dance on a tightrope when it ruled on an Indiana abortion ban. The justices upheld parts of the law, which dictate that fetal remains need to be buried or cremated, but they went ahead and sidestepped ruling on the constitutionality of the right to an abortion. The move signals that they might not be super eager to move aggressively on the issue, despite the way states keep trying to send them cases.
The New York Times: Supreme Court Sidesteps Abortion Question in Ruling on Indiana Law
Speaking of … Louisiana’s Democratic governor broke with his party this week to sign “heartbeat” legislation. Though it wasn’t a surprise (Gov. John Bel Edwards has been vocal about his support of the bill), it’s notable in a political landscape where many are left wondering if there’s any room left in the Democratic Party for anti-abortion politicians.
The Associated Press: Louisiana’s Democratic Governor Signs Abortion Ban Into Law
Although many people do have their eyes on the cases that are designed to challenge Roe v. Wade, an argument can be made that abortion opponents have already won the ground game. Even if Roe is upheld, opponents have taken enough bites of the apple over the past several years that the landscape looks a lot different than it once did. Considering mandatory waiting periods, clinic deserts, the missed wages and work that comes with traveling to get the procedure done, and the hostility that doctors and clinic staff face from protesters, for a lot of women — low-income women, especially —getting an abortion is already a monumental task.
Politico: Even If Roe Is Upheld, Abortion Opponents Are Winning
On that note (as of press time) a judge in Missouri is considering whether to intervene in a standoff that could leave the state’s last remaining abortion clinic shuttered as of midnight Friday.
The Associated Press: Judge Considering Missouri Abortion Clinic License Case
The Friday Breeze
Want a roundup of the must-read stories this week chosen by KHN Newsletter Editor Brianna Labuskes? Sign up for The Friday Breeze today.
Please confirm your email address below:
As President Donald Trump prepares an executive order geared toward increasing transparency across the health industry, some parties are making such a ruckus over a particular element that it might get dropped in the final version. At issue is a requirement that insurers and hospitals disclose for the first time the discounted rates they negotiate for services. “There is good transparency and bad transparency,” Kristine Grow, spokeswoman for America’s Health Insurance Plans, told The Washington Post. “This is bad transparency, because it is highly likely to cause prices to go up for everyone.”
The Washington Post: White House Runs Into Health-Care Industry Hostility as It Plans Executive Order
And elsewhere on the unhappy insurers front: Connecticut lawmakers have pressed pause on their push for a public option. The reason? Blowback from insurers. While I’m sure it’s more complicated than I’m making it, I was left wondering if the lawmakers had thought insurers were going to like it.
The Wall Street Journal: Connecticut’s Public Health Bill Stalls on Industry Concerns
HHS is proposing to roll back protections for transgender patients by mandating that “gender identity” is not protected under federal laws that prohibit sex discrimination in health care. A court challenge is almost certain, and patients are unlikely to feel any immediate impact from the proposal. But advocates see it as another move in the administration’s attempts to chip away at transgender rights.
The Associated Press: Administration Moves to Revoke Transgender Health Protection
A major opioid trial kicked off this week in Oklahoma with some fighting words thrown out by state Attorney General Mike Hunter. Hunter accused Johnson & Johnson — which is the sole remaining plaintiff in the case after the other companies settled — of using a “deceitful, multibillion-dollar brainwashing campaign” to dupe doctors into prescribing the opioids. The tricky part of the case is that painkillers are regulated and approved medication, and pinning the crisis on one company might be an uphill battle for the attorney general’s office. Still, the eyes of the nation are on the trial as a precursor to larger ones that are coming up.
Bloomberg: Oklahoma Opioid Trial Against Johnson & Johnson Begins
On Memorial Day (yes, it was this week, doesn’t it feel like ages ago?), the Army sent out a tweet asking veterans about how their service has affected them. The responses may not have been what officials were anticipating, though. Many vets wrote in about their mental health struggles with PTSD, creating a conversation about some of the darker aspects of returning home.
The New York Times: U.S. Army’s Tweet Prompts Stories of Harmful Effects of Military Service
Separately, 2020 hopeful Rep. Seth Moulton, a military veteran, shared his experiences with PTSD as he released a plan that would require mandatory mental health care checkups for returning military personnel.
Politico: Seth Moulton Discloses PTSD, Unveils Military Mental Health Proposal
And, not everyone comes home with PTSD. Can the ones who don’t teach us about caring for the ones who do?
The New York Times: I’m a Veteran Without PTSD. I Used to Think Something Was Wrong With Me.
How much is a miracle worth? That’s the question on the front burner once again now that the FDA has approved the world’s more expensive drug (with a price tag of over $2 million). Experts say it’s not so much the drug itself that’s the problem, but that it sets a new, higher benchmark for what people will end up paying for lifesaving drugs. Because there are plenty more coming behind it.
The Associated Press: At $2M, Priciest Ever Medicine Treats Fatal Genetic Disease
In the miscellaneous file for the week:
• Check out this fascinating and terrifying story about a children’s hospital where even low-risk patients were dying after surgeries. Audio obtained by The New York Times gives an unfiltered look at conversations between the doctors, which can boil down to: “Oh, my God … this is beyond horrifying.”
The New York Times: Doctors Were Alarmed: ‘Would I Have My Children Have Surgery Here?’
• A Chicago nursing home’s debacle shines a light on the vulnerabilities of a HUD program that has become a linchpin in the nation’s elder care system. It’s a program that most people don’t even realize exists but could be an Achilles’ heel for the government.
The New York Times: A Nursing Home Chain’s Collapse Leaves the Government on The Hook
• In a world where “Oh no, females are so complicated, so we just don’t study them” is a normal and expected thing to say, some researchers are trying to fight for more representation in clinical trials. But just saying there should be X number of women isn’t enough. Scientists need to go further, some say.
The New York Times: Fighting the Gender Stereotypes That Warp Biomedical Research
• Why is it Republicans who are gravitating toward the anti-vaccination movement? In the past, the party viewed it as a civic responsibility to get kids vaccinated, while resistance more often came from liberal enclaves. Today, the debate is becoming entangled with the idea of freedom from the government — and is wooing some Republicans.
Politico: How the Anti-Vaccine Movement Crept Into the GOP Mainstream
That’s it from me! Have a great weekend.
From:: KHN uninsured